NEWS & EVENTS
Dr. Ling is featured at professional gatherings around
the world as a speaker and presenter. He is frequently
cited in non-scientific press for his expert opinions on
substance abuse, addiction, pain medication and the
At right, Dr. Ling presents "Mastering the Addicted Brain"
to Siriwanwari Narirat Ratchakanya, a Princess of the
Kingdom of Thailand.
American Society of Addiction Medicine
San Diego, California, April, 2018
"Most of the drug studies up to now measure two things -- retention and drug use," said Walter Ling, MD, of the University of California Los Angeles, during a poster presentation at the American Society of Addiction Medicine annual meeting here. "We don't measure getting a life."
See the full coverage in MedPage Today.
Impact of RBP-6000 (Once-Monthly Depot Buprenorphine) on Patient-Reported Outcomes: A Long-Term Study
News provided by Indivior PLC, April, 2018
"Addressing opioid use disorder is about more than abstinence from substance abuse. As a clinician, I also speak with my patients about having a job, health insurance and their relationships with family, as these are important factors for reengaging with society," said Walter Ling, M.D., Professor Emeritus of Psychiatry and Founding Director of the Integrated Substance Abuse Programs (ISAP), University of California, Los Angeles, and lead author. "The study showed that patients seeking medication who received SUBLOCADE for up to 12 months were satisfied with the medication and reported positive recovery-related outcomes1. The Treatment Effectiveness Assessment showed that patients in the de novo cohort reported a steady improvement in substance abuse, health, lifestyle and community outcomes."
Academy of Psychosomatic Medicine
Annual Conference, 8 November 2017
Palm Springs, California, November, 2017
International Society of Addiction Medicine
19th Annual Conference
Abu Dhabi, UAE, October 2017